| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erythropoietin receptor | 0.526 | 0.692 | 1.0E-02 |
|
disease | 0.370 | None | 1.000 | 7 | 1 | 1992 | 2009 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1979 | 1979 | ||||||||
|
dihydroorotate dehydrogenase (quinone) | 0.576 | 0.769 | 3.0E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1979 | 1979 | ||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1979 | 1979 | ||||||||
|
hemoglobin subunit beta | 0.494 | 0.808 | 1.2E-09 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1980 | 2017 | ||||||||
|
Fli-1 proto-oncogene, ETS transcription factor | 0.468 | 0.692 | 0.99 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1992 | 2018 | ||||||||
|
FLII actin remodeling protein | 0.520 | 0.808 | 5.5E-12 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1992 | 2018 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 1987 | 2018 | ||||||||
|
hemoglobin subunit gamma 1 | 0.615 | 0.538 | 0.57 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1986 | 2018 | ||||||||
|
hemoglobin subunit gamma 2 | 0.565 | 0.692 | 0.67 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1986 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2008 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.917 | 12 | 1 | 1993 | 2019 | ||||||||
|
Spi-1 proto-oncogene | 0.631 | 0.654 | 0.98 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1990 | 2017 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1990 | 2017 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.100 | None | 1.000 | 10 | 1 | 2006 | 2019 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 1983 | 2002 | ||||||||
|
RAB8A, member RAS oncogene family | 0.610 | 0.577 | 0.98 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1985 | 2018 | ||||||||
|
nuclear factor, erythroid 2 | 0.628 | 0.577 | 0.67 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1995 | 2018 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2018 | ||||||||
|
TAL bHLH transcription factor 1, erythroid differentiation factor | 0.505 | 0.731 | 0.57 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2018 | ||||||||
|
deoxyribonuclease 1 | 0.505 | 0.846 | 7.0E-21 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1988 | 2001 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2009 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1991 | 2019 |